Introduction {#s1}
============

Mental illness is a major and fast-growing cause of morbidity worldwide ([@c101]). At the same time, ambient air pollution causes approximately 3 million premature deaths globally per year ([@c108]). Both problems disproportionately affect deprived groups ([@c38]; [@c49]) and can show marked urban--rural differences ([@c56]; [@c89]).

Air pollution contains many individual pollutants, including particulate matter (PM), gaseous pollutants and metallic and organic compounds. In this systematic review, we have focused on PM---itself a complex, heterogeneous mixture---because it is responsible for the largest proportion of air pollution's physical health impacts ([@c108]) and there is mounting evidence for tenable mechanisms by which it might affect risk of multiple mental health outcomes. Inflammation involving the central nervous system (CNS; neuroinflammation), has been implicated as having an important role in the pathophysiology of both depression ([@c65]) and psychosis ([@c9]). Hypothalamo--pituitary--adrenal (HPA) axis dysregulation has also been implicated in depression ([@c66]). The plausibility of these as potential etiological pathways between PM exposure and such outcomes is backed up by evidence from animal and human studies into the pathophysiological effects of PM exposure. For example, PM exposure has been shown to be associated with markers of neuroinflammation such as glial activation and oxidative stress in humans (e.g., [@c12]; [@c19]; [@c13]) and rodents (e.g., [@c59]; [@c39]); with changes in brain structure, as shown in humans (e.g., [@c18]) and animals (e.g., [@c39]); and with increased stress hormone (cortisol) production (e.g., [@c60]).

There is also emerging evidence to suggest that PM may adversely affect cognitive development ([@c113]), cognitive performance ([@c25]; [@c40]), and dementia risk ([@c23]) as well as stress and psychological well-being (e.g., [@c71]; [@c78]). Taken together, these findings demonstrate the wide-ranging impacts of PM on brain health and functioning and may support the hypothesis of an association with clinically relevant mental health outcomes.

Prior to our systematic review, we searched the Cochrane Library, PROSPERO, and PubMED for previous or in-progress reviews of air pollution and mental health outcomes. Previous reviews have focused more specifically on cognitive outcomes ([@c47]; [@c98]) or pollutants other than PM ([@c68]). Attademo et al. ([@c6]) reviewed the association between psychosis and a wide range of pollutants. In addition to evidence for associations with exposure to heavy metals, they identified four studies investigating associations with PM exposure and concluded that it "appear\[s\] to play an influential role" in schizophrenia. However, several of the individual reports identified are exploratory in nature and study quality was not assessed.

Our aim was to build on the work reported in the above reviews and provide a comprehensive overview of the epidemiological evidence, from human observational studies, for associations between PM exposure and depression, anxiety, bipolar disorder, psychosis, and suicide, using meta-analysis where appropriate. We also set out to appraise the quality of this evidence, highlighting key gaps and limitations in the current research. These aims are particularly relevant and timely given that some of the previously conducted reviews adopted a narrower scope regarding the outcomes and/or timeframes included and because additional studies have since been published.

Methods {#s2}
=======

Systematic Review and Selection Criteria {#s2.1}
----------------------------------------

We carried out a systematic review and meta-analysis to assess the evidence from human observational studies for associations between PM and adverse mental health outcomes in adults. We excluded experimental or laboratory-based study designs given that these can offer only limited evidence of causal effects on clinically relevant mental health outcomes. We registered the protocol with PROSPERO (registration identification CRD42017074598). Protocol development and reporting were guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist and flow diagram ([@c73]).

Inclusion and exclusion criteria, grouped according to the population--exposure--comparator-outcome (PECO) framework ([@c75]), were as follows. We required studies to meet all of the following criteria to be eligible for inclusion: Population---studies including adults ($\geq 18$ years of age).Exposures---studies of outdoor PM $< 2.5\;\mu m$ in aerodynamic diameter (${PM}_{2.5}$), $< 10\;\mu m$ in aerodynamic diameter (${PM}_{10}$), and $< 1\;\mu m$ in aerodynamic diameter (ultrafine particles, or UFPs), collectively termed PM.Comparators---observational studies reporting comparative effect estimates (i.e., comparing risk between individuals exposed to different levels of PM or different exposures within individuals at different time points).Outcomes---studies reporting incident or prevalent depression, anxiety, bipolar disorder, or psychosis, including validated symptom-based measures using screening or diagnostic instruments, and clinician diagnoses (recorded or self-reported), emergency department (ED)/clinic attendance or hospitalization for psychiatric disorders, and attempted or completed suicide as outcomes.English-language full-text available.

We excluded studies meeting the following descriptions: Population---studies restricted to children and pregnant women or individuals with chronic diseases (although we considered studies which included such populations in subgroup analyses eligible).Exposures---studies using only a proxy measure of PM, such as distance from a major road, road density, or traffic intensity or solid air-suspended particles (rather than measurements of ${PM}_{2.5}$, ${PM}_{10}$, or UFP concentrations); studies investigating indoor or cigarette-related air pollution; and studies of occupational air pollution exposure (e.g., firefighters).Comparators---studies without comparison between higher and lower levels of PM exposure.Outcomes---studies without an assessed outcome meeting the above criteria (e.g., studies that used measures of stress/psychological distress and studies that used medication prescribing data as their only outcome). We excluded studies using only unvalidated symptom-based measures for outcome assessment from the primary meta-analyses, although not from sensitivity analyses.

Search Terms and Sources {#s2.2}
------------------------

We searched the Medline, PsycINFO, and EMBASE databases from 1 January 1974 (the start date of the EMBASE database) to 20 September 2017 via the OVID platform. We mapped search terms to each index using keywords for air pollution, particulate matter, ${PM}_{10}$, ${PM}_{2.5}$, and ultrafine particles, psychiatric disorders, depression, anxiety, bipolar, psychosis, suicide, and related terms (see Table S1). We checked reference lists and review papers identified for additional relevant citations.

Study Selection {#s2.3}
---------------

Two authors (I.B. and S.Z.) separately screened all retrieved citations' titles and abstracts, and reviewed all studies deemed potentially relevant in full. Selection decisions were made independently using the prespecified criteria above, tracked using a spreadsheet, and disagreements resolved through discussion.

Data Extraction {#s2.4}
---------------

I.B. and S.Z. extracted data from eligible studies using a standardized pre-piloted template, covering the following information for each citation: study design, case definition, data source(s), study location, age range, sex (if only one), population at risk, number of cases/outcomes, follow-up time (where applicable), baseline PM concentration (in micrograms per cubic meter), exposure lags investigated, and a summary of overall findings \[including direction and statistical significance of adjusted associations, such as risk, odds, or hazard ratios (RRs, ORs, and HRs, respectively)\]. Where results were reported only at selected lags, only in stratified analyses, or only in graphical form, we requested unpublished results from authors by email. We also extracted covariates adjusted for in the main adjusted models of each study, which are listed in Table S2.

Studies of Short- and Long-Term Associations {#s2.5}
--------------------------------------------

Within the air pollution epidemiological literature more widely, there does not appear to be a consensus definition regarding the threshold distinguishing short- from long-term air pollution exposure. Short-term exposure generally refers to mean exposure over periods of hours, days, or weeks (which should also be measured immediately or only a short time prior to outcome assessment; i.e., at a short lag), often assessed through time-series or case-crossover study designs. Long-term exposure generally refers to mean exposure over a period of years and, in some studies, of several months, typically assessed through cohort, cross-sectional, or case--control study designs (e.g., [@c107]; [@c16]). For this analysis, we grouped studies based on the duration of exposure assessment (short- and long-term). We defined studies investigating short-term exposure as those using measured or modeled exposure values for periods shorter than 6 months, as an intermediate threshold between the time periods typically considered short-term (days or weeks) and long-term ($\geq 1\; y$). We also required that the exposure assessment period finish within the 6 months prior to outcome assessment, in line with other reviews (e.g., [@c16]). Long-term exposure was operationalized as measured or modeled mean exposure values covering a time period equal to or longer than 6 months.

Short-term time-series, case-crossover, and hierarchical cluster analysis study designs used one or both of two types of exposure lag periods (cumulative and single lags); the term lag 0-2 (or equivalent) is used to denote the lagged cumulative exposure (i.e., the moving average of daily mean concentration on Day 0 (day of outcome), Day $- 1$ (day before outcome), and Day $- 2$ (two days before outcome), and so forth). Lag 2 (or equivalent terms) denotes the single-day mean exposure concentration 2 d before the outcome.

Study Quality Assessment {#s2.6}
------------------------

We assessed study quality using the validated Effective Public Health Practice Project (EPHPP) Quality Assessment Tool for Quantitative Studies ([@c72]; [@c5]; [@c96]), which was developed by the McMaster Evidence Review and Synthesis Centre for evaluating public health research across heterogeneous study designs, including observational studies. Quality assessment scores were not used to restrict inclusion in meta-analysis but, rather, for the readers' reference. I.B. and S.Z. assigned quality ratings for each component according to the EPHPP Quality Assessment Tool and guidance within the associated EPHPP Tool Dictionary (available online at <https://merst.ca/ephpp/> and <https://merst.ca/wp-content/uploads/2018/02/qualilty-assessment-dictionary_2017.pdf>, respectively). I.B. and S.Z. discussed individual component ratings to reach an agreed rating, and where disagreements arose, these studies were discussed with J.F.H. to determine final ratings. We assigned overall ratings according to the EPHPP guidance (those with one rating of poor were assigned an overall rating of fair, and those with two or more, an overall rating of poor).

We assessed selection bias, study design, confounders, blinding, data collection methods (outcome assessment), withdrawals and drop-outs (in longitudinal designs), and intervention/exposure integrity and analyses and assigned an overall rating for all but the last two. Table S3 provides a list of the questions within each component and summary descriptors for how each was allocated.

We extended the list of study designs assigned a moderate rating from those in the EPHPP Tool Dictionary roadmap to include time-series analysis, case-crossover, and hierarchical cluster analysis, provided they used bidirectional referent period selection (as per [@c20]). Cross-sectional studies of long-term exposure using an exposure period overlapping with or after outcome assessment were rated poor on study design, whereas cross-sectional studies of long-term exposure using PM values corresponding to a period prior to the outcome assessment period were rated moderate.

In assessing confounding risk, we did not assess the likelihood of differences by intervention (exposure) status given that PM exposure is continuous and we assumed all studies to be at risk of confounding. To assign a rating, we estimated the approximate proportion of relevant confounders controlled (through design or analysis) as follows. We deemed studies comparing risk between individuals to be vulnerable primarily to confounding by socioeconomic status/deprivation, lifestyle factors, health status, and urbanity and considered those that controlled for age, sex, urbanity, multiple relevant lifestyle factors, and for multiple indicators of socioeconomic status (e.g., education, income/household income, area-level measures of deprivation) to have controlled for $> 80\%$ of (most) relevant confounders; the rating threshold termed good. However, other potentially important confounders (such as noise exposure and access to green space) may not have been controlled for; we judged their (combined) effect as likely to represent $< 20\%$ of overall relevant confounders. Some adjustment for socioeconomic status and urbanity was required as a minimum for a (between-individual) study to be considered moderate quality with respect to confounding. We considered case-only designs, such as case-crossover analyses, which compare risk within each individual at different points in time, prone mainly to confounding by time-varying covariates (e.g., meteorological factors, seasonal variation, and day-of-the-week effects), and the risk of confounding was appraised accordingly.

Meta-Analysis and Standardization of Results {#s2.7}
--------------------------------------------

In addition to the eligibility criteria noted for inclusion in the systematic review, we conducted meta-analyses only when three or more eligible studies investigated associations between the same PM fraction and same outcome, analyzed dichotomous and continuous outcomes separately, and considered only results unstratified by season. We meta-analyzed the adjusted results of studies of associations with long-term PM exposure together, using the most similar time lags available in the primary meta-analysis, and without combining associations of PM exposure with incidence and prevalence in the same (primary) meta-analysis. We meta-analyzed studies of short-term exposure only at the same exposure lag, treating single and cumulative lags separately. Given the overlap between cumulative and single-day lags, we judged meta-regression not to be conceptually appropriate.

We did not use the overall EPHPP study quality ratings to determine eligibility for inclusion in meta-analyses; however, we required studies to have adjusted for a minimal set of confounders to be eligible for meta-analysis (primary or sensitivity analyses) and always used the results from the most comprehensively adjusted model. For studies of long-term exposure, we required adjustment for urbanicity and socioeconomic status or deprivation as a minimum for inclusion in meta-analysis. For studies of short-term exposure, we required adjustment for day of the week and temperature as a minimum.

We considered only results from whole-year analyses for inclusion, both because analyses stratified by season used heterogeneous seasonal cutoffs and because there is currently not sufficient evidence of seasonal effect modification of a putative association with PM to justify stratified analyses. For our primary meta-analysis we required the measures effect to be the same or to be convertible. This meant we did not meta-analyze studies reporting HRs alongside ORs or RRs. We assessed the impact of excluding these results in sensitivity analysis.

We conducted three primary meta-analyses: long-term ${PM}_{2.5}$ and depression risk; long-term ${PM}_{10}$ and depression risk, and short-term ${PM}_{10}$ and suicide risk (at two lag periods of 0-1 and 0-2 d).

We used DerSimonian-Laird random-effects meta-analysis ([@c31]), using the metan function in STATA, because of the heterogeneity in study populations, outcome definitions, and prevalence. We produced forest and funnel plots, and conducted all statistical analyses using STATA (version 14.0; Stata Corporation). Assuming a log-linear exposure--response relationship, we standardized ORs, RRs, and HRs for a $10\,{\mu g/m}^{3}$ PM increment---where expressed per $5\,{\mu g/m}^{3}$ PM increment, for example---before meta-analysis. To standardize these results, we used the formula $OR_{10} = e^{({\ln{({OR_{x}})} \times {(\frac{10}{x})}})}$ (substituting RR or HR as applicable), where $x$ is the increment of PM exposure ($5{\,\mu g/m}^{3}$ in this example) for which $OR_{x}$ is presented in the original study ([@c26]).

Sensitivity Analyses {#s2.8}
--------------------

We used sensitivity meta-analysis to explore the effect of the following changes on the results of meta-analyses of associations between depression and long-term ${PM}_{2.5}$ exposure (1a--c), and between depression and long-term ${PM}_{10}$ exposure (2a--b), Including HRs in meta-analysis with ORs (i.e., assuming equivalence)Including studies excluded from the primary meta-analysis on the basis of the outcome definitions used, for ${PM}_{2.5}$Including the same studies as the primary meta-analysis using alternative exposure time periods for studies which used more than one (${PM}_{2.5}$ only)Including the same studies as the primary meta-analysis but using the alternative exposure assessment model in studies using two models (${PM}_{10}$ only)Including the studies excluded from the primary meta-analysis on the basis of their outcome definitions, for ${PM}_{10}$ (as per 1b).

Assessment of Variability and Publication Bias {#s2.9}
----------------------------------------------

We assessed heterogeneity between meta-analyzed studies using forest plots (given the relatively small number of studies included, this approach was considered more appropriate than Cochran's *Q*) and assessed the percentage of between-study variation due to heterogeneity rather than within-study error with the $I^{2}$ statistic; we also calculated *p*-values for a chi-square test of heterogeneity. We analyzed funnel plots visually for evidence of publication bias and conducted Egger's regression test.

Illustrative Population Attributable Fraction Estimates {#s2.10}
-------------------------------------------------------

Where meta-analyses of associations with long-term exposure yielded statistically significant summary estimates, we estimated illustrative population attributable fractions (PAFs) for two separate exposure scenarios (UK cities and global). For this purpose, we assumed causality (while noting that this has not been proven), equivalence between ORs and RRs (the rare outcome assumption), and a log-linear exposure--response function (i.e., that relative risk remains constant per unit increase in exposure, at all concentrations). The latter assumption is frequently adopted in air pollution epidemiology in relation to physical health outcomes (e.g., [@c29]).

We estimated PAFs by assuming 100% exposure prevalence at population-weighted mean PM exposure levels, using published population-weighted exposure estimates for UK urban ([@c35]) and global ([@c14]) populations ($12.8{\,\mu g/m}^{3}$ and $43.9{\,\mu g/m}^{3}$, respectively). The counterfactual scenarios we used were those of population-weighted average exposure being reduced to the World Health Organization's (WHO) recommended limit for annual mean ${PM}_{2.5}$ ($10.0{\,\mu g/m}^{3}$) for UK cities ([@c57]), and to the European Union's (EU) less stringent recommended limit value ($25.0{\,\mu g/m}^{3}$) for the global scenario ([@c34]).

To calculate PAFs, we adapted the following formula used by the WHO ([@c108]): $$PAF = \frac{\sum_{i = 1}^{n}P_{i}\left( {RR - 1} \right)}{\sum_{i = 1}^{n}P_{i}\left( {RR - 1} \right) + 1},$$where *i* is the level of ${PM}_{2.5}$ in micrograms per cubic meter, $P_{i}$ is the percentage of the population exposed to that level of air pollution, and *RR* is the relative risk (compared with the counterfactual scenario; see below). Assuming uniform and ubiquitous exposure at a specified mean level, based on a population-weighted exposure estimate, this simplifies to $$PAF = \frac{1.00\left( {RR - 1} \right)}{1.00\left( {RR - 1} \right) + 1}.$$

For this purpose, we treated pooled ORs obtained from meta-analysis as equivalent to RRs, and estimated the RR under the current relative to counterfactual ${PM}_{2.5}$ exposure scenarios outlined above as $${RR \approx \, OR_{10}}^{\frac{({PM}2.5_{current} - {PM}2.5_{counterfactual})}{10}},$$where $OR_{10}$ denotes the OR per $10{\text{-}\mu g/m}^{3}$ increment in ${PM}_{2.5}$ exposure used. Calculations are detailed in Table S4.

Results {#s3}
=======

The study selection process is summarized in [Figure 1](#f1){ref-type="fig"}. We identified 25 eligible studies (from 22 citations, 1 of which included four data sets combined in one paper as a meta-analysis ([@c115]) ([Tables 1](#t1){ref-type="table"}--[3](#t3){ref-type="table"}) from 1,829 citations screened; most investigated outcomes were related to depression, suicide, or ED/hospital attendance.

![Study selection diagram (studies published between 1 January 1974 and 20 September 2017).](ehp-127-126002-g001){#f1}

###### 

Summary of observational studies of long-term exposure to particulate air pollution (exposure assessment periods of $\geq 6\text{ \ months}$ duration) and adult mental health outcomes published between 1 January 1974 and 20 September 2017.

Table 1 lists References in the first column; the corresponding Study design, Case definition, Outcome data source, Study location, Age range, sex (if only one), Population at risk, Number of cases/ out-come events, Follow-up time (where applicable) and years of outcome assessment, Baseline PM concentrations, Exposure assessment period(s), and Summary of overall findings---direction and significance of adjusted associations are listed in the other columns.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference        Study design   Case definition                                                                                                                                                                        Outcome data source                                                   Study location                                      Age (y)                                    Population at risk   Cases or out-come events (*n*)                            Follow-up time (years of outcome assessment)   Baseline PM concentrations (${\mu g/m}^{3}$)[^*a*^](#TF2){ref-type="table-fn"}   Exposure assessment period(s)                                                                                                                                        Summary of overall findings: direction and significance[^*b*^](#TF3){ref-type="table-fn"} of adjusted associations
  ---------------- -------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------- ------------------------------------------ -------------------- --------------------------------------------------------- ---------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@c53]           OC             Depression incidence - first recorded diagnosis of major depression (ICD-10 codes F32.x) with an antidepressant prescription                                                           National Health Insurance Database                                    Seoul, Republic of Korea                            15--79                                     27,270               973                                                       3 y (2008--2010)                               ${PM}_{2.5}$: $26.7$ (2007--2010 average)                                        Annual mean level of ${PM}_{2.5}$ in 2007, 4-y mean ${PM}_{2.5}$ (2007--2010) 12-month moving average of ${PM}_{2.5}$ until an event or censor (during 2007--2010)   Associations at all exposure periods investigated all positive and significant (fully adjusted model). $\text{HR\  } =$ 1.47 (95% CI: 1.14, 1.90) per $10{\text{-}\mu g/m}^{3}$ increase in 12-month ${PM}_{2.5}$ (moving average over 1 y before outcome)

  [@c52]           C-S            Depressive experience (Yes response to binary question), detailed here, and self-rated stress (not eligible for this review)                                                           Survey with questionnaire (cross-sectional)                           25 districts in Seoul, Republic of Korea            $\geq 19$                                  23,139               1,675                                                     N/A (C-S) Outcome data collected: 2013         ${PM}_{10}$: $44.6$                                                              Annual mean level of ${PM}_{10}$ in 2013                                                                                                                             Depression experience:N-S association with 1-y ${PM}_{10}$: $\text{OR} =$ 1.01 (95% CI: 0.98, 1.05) per $10{\text{-}\mu g/m}^{3}$ increase in ${PM}_{10}$ in 2013

  [@c55]           OC             Depression incidence - first self-report of either a physician diagnosis of depression or antidepressant medication use                                                                Written questionnaire (within Nurses' Health Study)                   USA                                                 50--75[^*a*^](#TF2){ref-type="table-fn"}   41,844               5,003                                                     14 y (1996--2008)                              1-y mean ${PM}_{2.5}$: $12.6$                                                    1-, 2-, and 5-y mean ${PM}_{2.5}$ prior to outcome assessment                                                                                                        N-S associations with diagnosis and first reported antidepressant use combined (the authors' primary outcome definition): $\text{HR} =$ 1.08 (95% CI: 0.97, 1.20) and with diagnosis: $\text{HR\  } =$ 0.98 (95% CI: 0.84, 1.15)

  [@c63]           CS             Depression prevalence - any of: *a*) depressive symptoms within the past year, *b*) meeting diagnostic criteria for research, or *c*) having received depression-related health care   Survey with questionnaire (questions from CIDI, WMH Survey version)   China, Ghana, India, Mexico, Russia, South Africa   $> 18$                                     41,785               3,189                                                     N/A                                            Mean ${PM}_{2.5}$: $23.75$                                                       3-y moving average mean ${PM}_{2.5}$ prior to survey (SAGE Wave 1, conducted from 2007 to 2010 across 6 countries ([@c64])                                           Positive, significant association between depression and ambient ${PM}_{2.5}$. Adjusted OR for association with 3-y ${PM}_{2.5}$: 1.10 (95% CI: 1.02, 1.19) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$

  [@c100]          C-S            4 separate outcomes - self-reported history of depression or anxiety disorder, benzodiazepine or antidepressant use                                                                    Survey with face-to-face interviews                                   Barcelona, Spain                                    45--74                                     958                  Self-reported depression: 13; self-reported anxiety: 21   N/A                                            Median ${PM}_{2.5}$: $16.3$; Median ${PM}_{10}$: $37.7$                          2009 modeled values (from ESCAPE), using 2013--2014 address data                                                                                                     Positive, significant association between self-reported depression and both PM fractions: $\text{OR\  } =$ 6.52 (95% CI: 1.82, 23.35) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{10}$, $\text{OR\  } =$ 4.38 (95% CI: 1.70, 11.30) per $5{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$). Positive, N-S associations between self-reported anxiety and both PM fractions: $\text{OR\  } =$ 1.33 (95% CI: 0.48, 3.68) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{10}$, $\text{OR\  } =$ 1.49 (95% CI: 0.62, 3.58) per $5{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$

  [@c115]\                                                                                                                                                                                                                                                                                     4 European cohorts:                                                                            70,928 total:                                                                                                                                                                                                  Measurement periods:                                                                                                                                                 Main model results:
  Substudies:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   A (LifeLines)   C-S            Depressive symptoms - MINI diagnostic interview ($\geq 5$ symptoms; $\geq 1$ key symptom)                                                                                              Standardized face-to-face interviews                                   3 Northern provinces (Netherlands)                 $\geq 18$                                  32,145               681 (2.1%)                                                N/A Outcome data: 2007--2013                   ${PM}_{10}$: $23.95$; ${PM}_{2.5}$ $15.4$ (medians)                               ESCAPE (2009--2010); EU-wide (2007)                                                                                                                                  Positive, N-S association for ${PM}_{2.5}$: $\text{OR\  } =$ 1.04 (95% CI: 0.32, 3.40) per $5{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Negative, N-S association for ${PM}_{10}$ (ESCAPE): $\text{OR\  } =$ 0.43 (95% CI: 0.07, 2.62) per $10{\text{-}\mu g/m}^{3}$${PM}_{10}$.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Negative, N-S association for ${PM}_{10}$ (EU-wide): $\text{OR\  } =$ 2.89 (95% CI: 1.43, 5.85) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{10}$

   B (KORA)        C-S            Depressive symptoms - PHQ-9 diagnostic interview version ($\geq 5$ symptoms; $\geq 1$ key symptom)                                                                                     Standardized face-to-face interviews                                   Augsburg area, Germany                             $\geq 18$                                  5,314                87 (1.6%)                                                 N/A Outcome data: 2004--2005, 2006--2008       Not stated                                                                        ESCAPE (2008--2009); EU-wide (2005--2007 average)                                                                                                                    Positive, N-S association for ${PM}_{2.5}$: $\text{OR\  } =$ 1.06 (95% CI: 0.25, 4.51) per $5{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Negative, N-S association for ${PM}_{10}$ (ESCAPE): $\text{OR\  } =$ 0.81 (95% CI: 0.31, 2.13) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{10}$.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Negative, N-S association for ${PM}_{10}$ (EU-wide): $\text{OR\  } =$ 0.48 (95% CI: 0.06, 3.91) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{10}$

   C (HUNT)        C-S            Depressive symptoms - score of $\geq 10$ on HADS-D questionnaire                                                                                                                       Self-administered written questionnaire                                Nord-Trøndelag area, Norway                        $\geq 18$                                  32,102               1,226 (3.8%)                                              N/A Outcome data: 2006--2008                   Median ${PM}_{10}$: $11.0$                                                        EU-wide (2006--2007 average)                                                                                                                                         No main adjusted model results (alternative confounder model used not adjusted for education, household income, or urbanicity). Results of minimal confounder model for ${PM}_{10}$ (EU-wide): $\text{OR\  } =$ 0.38 (95% CI: 0.21, 0.68) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{10}$

   D (FINRISK)     C-S            Depressive symptoms - score of $\geq 21$ on CESD questionnaire                                                                                                                         Self-administered written questionnaire                                Helsinki, Vantaa, Turku (Finland)                  $\geq 18$                                  1,367                155 (11.3%)                                               N/A Outcome data: 2007                         Not stated                                                                        ESCAPE (2010--2011)                                                                                                                                                  Positive, N-S associations for both ${PM}_{2.5}$: $\text{OR\  } =$ 1.39 (95% CI: 0.64, 3.05) per $5{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$ and ${PM}_{10}$: $\text{OR\  } =$ 1.08 (95% CI: 0.50, 2.33) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{10}$
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: CESD(-R), Centre for Epidemiologic Studies Depression scale (-Revised); CIDI, Composite International Diagnostic Interview; C-S, cross-sectional; GAD, generalized anxiety disorder; HADS, Hospital Anxiety and Depression Scale; HR, hazard ratio; ICD, International Classification of Diseases; MDD, major depressive disorder; MINI, Mini-International Neuropsychiatric Interview; N-S, nonsignificant; OC, observational cohort; OR, odds ratio; PHQ-9, Patient Health Questionnare-9; ${PM}_{10}$, particulate matter of $< 10\;\mu m$ in aerodynamic diameter; ${PM}_{2.5}$, particulate matter of $< 2.5\;\mu m$ in aerodynamic diameter; PYAR, person-years at risk; Sz, schizophrenia; WMH Survey, World Mental Health Survey.

Mean PM values are given except where otherwise stated.

Significance refers to statistical significance at the 95% level.

###### 

Summary of observational studies of associations between long- and short-term exposure (exposure assessment periods of $\geq 6$ and $< 6\text{ \ months}$ duration) to particulate air pollution and adult mental health outcomes published between 1 January 1974 and 20 September 2017.

Table 2 lists References in the first column; the corresponding Study design, Case definition, Outcome data source, Study location, Age range, sex (if only one), Population at risk, Number of cases/outcome events, Follow-up time (where applicable) and years of outcome assessment, Baseline PM concentrations, Exposure assessment duration, and Summary of overall findings---direction and significance of adjusted associations are listed in the other columns.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference   Study design                    Case definition                                                                                                Outcome data source                                   Study location   Age (y)                                    Population at risk                           Cases or out-come events (*n*)                              Follow-up time (years of outcome assessment)                                                      Baseline PM concentrations (${\mu g/m}^{3}$)[^*b*^](#TF6){ref-type="table-fn"}                 Exposure assessment duration(s)                                                                                     Summary of overall findings---direction and significance[^*c*^](#TF20){ref-type="table-fn"} of adjusted associations
  ----------- ------------------------------- -------------------------------------------------------------------------------------------------------------- ----------------------------------------------------- ---------------- ------------------------------------------ -------------------------------------------- ----------------------------------------------------------- ------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@c87]      OC                              Phobic and generalized anxiety symptoms---score $\geq 6$ on Crown Crisp Index phobic anxiety subscale          Written questionnaire (within Nurses' Health Study)   USA              57--85[^*a*^](#TF5){ref-type="table-fn"}   71,271 total: 69,966---valid exposure data   10,818                                                      N/A Outcome data: 2004 questionnaire responses                                                    ${PM}_{2.5}$, 1988--2003: $13.8{\,\mu g/m}^{3}$, 1-month ${PM}_{2.5}$: $12.7{\,\mu g/m}^{3}$   1-, 3-, and 6-months, 1 and 15 y prior to outcome assessment                                                        Positive, significant associations at all time lags. e.g., 1-y exposure: $\text{OR\  } =$ 1.15 (95% CI: 1.06, 1.25) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$

  [@c88]      Panel study, nested within OC   Moderate-to-severe depressive (CESD-11 score $\geq 9$) or anxiety symptom (HADS-A score $\geq 8$) prevalence   Written questionnaire (within NSHAP Study)            USA              57--85                                     4,008 (6,382 observations)                   1,433 with depressive symptoms; 983 with anxiety symptoms   N/A July Outcome assessment: Wave 1 (July 2005 to March 2006); Wave 2 (August 2010 to May 2011)   ${PM}_{2.5}$: $11.1{\,\mu g/m}^{3}$ (Wave 1), $8.8{\,\mu g/m}^{3}$ (Wave 2)                    Cumulative lagged (moving average) exposure for 7, 30, 180 d, and 1 and 4 y immediately before outcome assessment   Depressive symptoms: significant associations identified at 7- and 30-d lags; positive but N-S at longer lags. 1-y $\text{OR\  } =$ 1.06 (95% CI: 0.89, 1.27) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Anxiety symptoms: positive and significant at all lags studies. 1-y $\text{OR\  } =$ 1.39 (95% CI: 1.15, 1.69) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: CESD-11, Centre for Epidemiologic Studies Depression scale (11-item version); HADS, Hospital Anxiety and Depression Scale; ICD, International Classification of Diseases; N-S, nonsignificant; NSHAP, National Social Life, Health and Aging Project; OC, observational cohort; OR, odds ratio; ${PM}_{10}$, particulate matter of $< 10\;\mu m$ in aerodynamic diameter; ${PM}_{2.5}$, particulate matter of $< 2.5\;\mu m$ in aerodynamic diameter.

Females only.

Mean PM values are given except where otherwise stated.

Significance refers to statistical significance at the 95% level.

###### 

Summary of observational studies of short-term exposure to particulate air pollution (exposure assessment periods of $< 6\text{ \ months}$ duration) and adult mental health outcomes published between 1 January 1974 and 20 September 2017.

Table 3 lists References in the first column; the corresponding Study design, Case definition, Outcome data source, Study location, Age range, sex (if only one), Population at risk, Number of cases/ outcome events, Follow-up time (where applicable) and years of outcome assessment, Baseline PM concentrations, Exposure assessment duration or lag, and Summary of overall findings---direction and significance of adjusted associations are listed in the other columns.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference   Study design                    Case definition                                                                                                                                                                              Outcome data source                              Study location                      Age (y)       Population at risk     Cases or out-come events (*n*)                                   Duration                                                                          Baseline PM concentrations (${\mu g/m}^{3}$)[^*a*^](#TF8){ref-type="table-fn"}   Exposure assessment duration or lag[^*b*^](#TF9){ref-type="table-fn"}                                                                                                           Summary of overall findings---direction and significance[^*c*^](#TF10){ref-type="table-fn"} of adjusted associations
  ----------- ------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------ ----------------------------------- ------------- ---------------------- ---------------------------------------------------------------- --------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@c8]       CCO                             All registered suicide deaths                                                                                                                                                                Mortality data, Office of the Medical Examiner   Salt Lake County, Utah, USA         All ages      N/A (case-only)        1,546                                                            11 y (2000--2010)                                                                 ${PM}_{2.5}$: 10.95--11.38; ${PM}_{10}$: $32.21–33.21$ (ranges)                  Single lags: 0, 1, 2, 3; Cumulative lags: 0-1, 0-2, 0-3                                                                                                                         Positive, significant association with ${PM}_{2.5}$ at lag 2 (unstratified by sex), and lag 3 in males. Positive, N-S increases for ${PM}_{10}$ at all lags except lag 0.

  [@c21]      CCO                             All registered suicide deaths (ICD-10 codes X60--X84 (intentional self harm---90% of cases) or codes Y10--Y34 (event of undetermined intent)                                                 National Belgian Population Register             Belgium                             All ages      N/A (case-only)        21,231                                                           10 y (2002--2011)                                                                 ${PM}_{10}$ (event days): $29.0$                                                 Cumulative lags: 0-1, 0-2, 0-3, 0-4, 0-5, 0-6 d                                                                                                                                 N-S association with ${PM}_{10}$ across the whole year. Positive, significant association in summer.

  [@c51]      CCO                             All registered suicide deaths (confirmed date of death/date of hospital attendance if dead on arrival)                                                                                       National Statistical Office database             7 cities in the Republic of Korea   All ages      N/A (case-only)        4,341                                                            1 y (2004)                                                                        ${PM}_{10}$: $50.85$; ${PM}_{2.5}$: $29.9$                                       Single lags: 0, 1, 2, 3 d; Cumulative lags: 0-1, 0-2, 0-3 d                                                                                                                     Associations at 0, 1, 2, and 0-1, 0-2, 0-3 d lags were positive and significant; lag 3 was N-S. (Random effects results)

  [@c62]      CCO                             All registered suicide deaths (ICD 10:X60-84)                                                                                                                                                Guangzhou CDCP mortality register                Guangzhou, China                    All ages      N/A (case-only)        1,550                                                            10 y (2003--2012)                                                                 ${PM}_{10}$: $79.6$                                                              Single lags: 0, 1, 2, 3, 4, 5, 6, 7 d; Cumulative lags: 0-1, 0-2, 0-3, 0-4, 0-5, 0-6, 0-7 d                                                                                     Significant positive association at lags 0-1 and 0-2, otherwise positive but N-S, except at lag days 5, 6, 7 (negative, N-S)

  [@c76]      CCO                             All registered suicide deaths (ICD-10 codes X60--X84)                                                                                                                                        National mortality register                      Tokyo, Japan                        All ages      N/A (case-only)        29,939                                                           11 y                                                                              ${PM}_{2.5}$: $18.66–19.66$                                                      Same day (0); Cumulative lags: 0-1, 0-2, 0-3 d                                                                                                                                  N-S associations with ${PM}_{2.5}$ at all lags studied, no consistent direction of effect observed.

  [@c54]      Time-series                     All registered suicide deaths (ICD-10 codes X60--X84)                                                                                                                                        National mortality register                      Republic of Korea                   All ages      N/A (case-only)        Mean rate: 29.1 per 100,000 PYAR                                 6 y (2006--2011)                                                                  ${PM}_{10}$: $51.63$                                                             Lagged weekly, not cumulative (single weekly lags 0-6)                                                                                                                          Positive, significant associations at lags 0, 2, 3, 4, strongest at 4 weeks. N-S associations at 1, 5, and 6 weeks.

  [@c95]      CCO and HCA                     ED visits coded as suicide attempt/ideation or mental health (separately); trauma referrals excluded as not accepted by this hospital                                                        ED attendance data                               Vancouver, Canada                   All ages      N/A (case-only)        1,605 suicide attempt/ ideation; 9,358 mental health ED visits   4.2 y (1 January 1999--28 February 2003)                                          ${PM}_{10}$: $25.8$; ${PM}_{2.5}$: $8.6$                                         Daily mean values and 1- and 2-d lagged values                                                                                                                                  Positive, N-S results for ${PM}_{10}$ and ${PM}_{2.5}$ in whole-year analyses, largest effect estimates at lags 1 and 2. Significant positive associations noted in cold season only. Results for mental health not reported.

  [@c43]      Time-series                     Psychiatric hospital admissions for any mental/behavioral disorder (ICD-10 codes F00--F99); also stratified by diagnosis (schizophrenia and mood disorders)                                  ED attendance data                               Beijing, China                      Unspecified   N/A (case-only)        13,291 total; 4,529 schizophrenia; 7,290 mood disorders          3 y                                                                               ${PM}_{10}$: $120.0$; ${PM}_{2.5}$: $88.8$                                       Single-day lags: 0, 1, 2, 3, 4, 5; Cumulative lags 0-2, 0-4, 0-6                                                                                                                ${PM}_{10}$: Positive, significant associations with unstratified admissions and schizophrenia; N-S for mood disorders ${PM}_{2.5}$: Positive, significant associations with total, mood disorder and schizophrenia admissions.

  [@c24]      CCO                             All ED attendances for depressive episode                                                                                                                                                    National Health Insurance program data           Seoul, Republic of Korea            All ages      N/A (case-only)        4,985                                                            4 y (2005--2009)                                                                  ${PM}_{10}$: $54.15$                                                             Single-day lags: 0, 1, 2, 3 d\                                                                                                                                                  Positive and significant in same-day model (lag 0), only significant for participants with any of the 5 comorbidities included at cumulative lag 0-3.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Cumulative lags: 0-1, 0-2, 0-3 d                                                                                                                                                

  [@c90]      HCA                             All ED visits for depression (ICD-9 rubric 311)                                                                                                                                              ED attendance data                               Edmonton, Canada                    All ages      N/A (case-only)        15,556                                                           10 y (1992--2002)                                                                 ${PM}_{10}$: $22.6$; ${PM}_{2.5}$: $8.5$                                         Single-day lags: 0 (same day), 1 and 2 d lags                                                                                                                                   ${PM}_{10}$ (lag not specified): Positive, significant association across whole year, unstratified by sex. ${PM}_{2.5}$: positive associations at lags 0 and 1, negative at 2, all N-S. Results for most lags presented graphically only.

  [@c92]      HCA                             ED visits for depression (ICD-9 rubric 296; 311 in Edmonton)                                                                                                                                 ED attendance data                               6 cities in Canada                  All ages      N/A (case-only)        27,047                                                           Average of 6 y at each study site (sum total across sites equivalent to 37.5 y)   ${PM}_{10}$: $19.4$; ${PM}_{2.5}$: $8.3$                                         Single-day lags: 0 (same day), 1 and 2 d lags                                                                                                                                   Unstratified by season: ${PM}_{10}$ (lag 0): Positive, significant association. ${PM}_{2.5}$ (lag 0): Positive, N-S association. N-S associations at 1- and 2-d lags.

  [@c91]      CCO                             ED visits for depression (all visits coded as F32 or F33, although described as mild and recurrent depression); also all mental and behavioral disorders (all ICD-10 codes with F- prefix)   National Ambulatory Care Reporting System        9 urban areas in Ontario, Canada    All ages      N/A (case-only)        118,602                                                          7.5 y (April 2004--December 2011)                                                 Mean ${PM}_{2.5}$ not presented: $\text{range} = 5.3–9.8$                        Cumulative lags: 0, 0-1, 0-2, 0-3, 0-4, 0-5, 0-6, 0-7, 0-8 d                                                                                                                    ${PM}_{2.5}$, depression (ICD-10 codes F32--F33): Pooled, whole year estimates (presented only stratified by sex): positive at lags 0-5, 7-8 for males and females at 0 and 2-7. Mostly N-S; significant at lag 3 in males. Results for analyses of all mental and behavioral disorders not reported.

  [@c61]      Panel study                     Depressive symptoms - SGDS-K score (continuous)[^*d*^](#TF11){ref-type="table-fn"}                                                                                                           Face-to-face interviews with questionnaire       Seoul, Republic of Korea            60--87        560; results for 537   N/A                                                              3 discrete follow-up periods over 3 y                                             ${PM}_{10}$: $43.7$                                                              Same day (0), cumulative lags: 0-2, 0-5, 0-7, 0-14, 0-21, 0-28 d                                                                                                                ${PM}_{10}$: Total SGDS-K scores positively and significantly associated with 3-d cumulative lagged exposure.

  [@c105]     Panel study, nested within OC   Depressive symptoms (CESD-R $\geq 16$)                                                                                                                                                       Face-to-face interview with questionnaire        Boston, USA                         $\geq 65$     732                    62 (8.5%)                                                        3 y                                                                               ${PM}_{2.5}$: $8.6$                                                              Cumulative lags: 0-1, 0-2, 0-3, 0-5, 0-7, and 0-14 d. Also long-term exposure using proximity to main road; this analysis was not eligible (hence listed as short-term only).   ${PM}_{2.5}$: Significant negative association with CESD-R score $\geq 16$ at 0-14d lag ($\text{OR} =$ 0.67; 95% CI: 0.46, 0.98) per interquartile range increase ($3.40{\,\mu g/m}^{3}$). No significant associations at shorter periods. 0- to14-d lagged UFP: $\text{OR} =$ 1.04 (95% CI: 0.68, 1.57) per $6,630{\text{ \ particles}/m}^{3}$ increase in cumulative lagged UFP exposure.
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: Where follow-up time is presented in days in the primary source, we converted this to years by dividing by 365 d/y. CCO, case-crossover; CESD(-R), Centre for Epidemiologic Studies Depression scale (-Revised); ED, emergency department; HCA, hierarchical cluster analysis; HR, hazard ratio; ICD, International Classification of Diseases; MDD, major depressive disorder; N-S, nonsignificant; OR, odds ratio; ${PM}_{10}$, particulate matter of $< 10\;\mu m$ in aerodynamic diameter; ${PM}_{2.5}$, particulate matter of $< 2.5\;\mu m$ in aerodynamic diameter; PYAR, person-years at risk; RR, relative risk; SGDS-K, Korean Geriatric Depression Scale-Short Form score; WMH Survey, World Mental Health Survey.

Mean PM values are given except where otherwise stated.

Lags refer to mean exposure over the specified period relative to the point of outcome assessment, such that single lag 2 denotes exposure 2 d prior to outcome assessment, whereas cumulative lag 0-2 denotes exposure on the day of outcome assessment as well as on the preceding 2 d, and so forth.

Significance refers to statistical significance at the 95% level.

Positive scores on SGDS-K were inverted by Lim et al. ([@c61]) so that higher overall scores indicate greater severity.

Two studies ([@c87]; [@c88]) included both short- and long-term exposure lags; 14 studies assessed associations with short-term exposure only, and 9 assessed associations with long-term exposure only. One study ([@c105]) categorized with studies of short-term PM exposure in our review also studied longer-term exposure; however, we excluded these analyses because they used road proximity rather than PM exposure.

Sample size ranged from 958 to 69,966 in studies including both cases and noncases (e.g., cohort and cross-sectional studies). Those adopting case-only study designs included between 1,546 and 118,602 individuals. Two studies ([@c55]; [@c87]) included only women, and 5 ([@c55]; [@c87]; [@c88]; [@c61]; [@c105]) included only older adults, with a range of age cutoffs. The most common study locations were Asia and North America; 14 were restricted to urban populations. Most studies identified were relatively recent, with only 8 published before 2015. Six of these used case-only study designs, whereas a higher proportion published since then adopted cross-sectional or cohort designs.

[Tables 1](#t1){ref-type="table"}--[3](#t3){ref-type="table"} summarize the key data extracted from included studies, divided according to the exposure timeframe, and [Figure 2](#f2){ref-type="fig"} summarizes study quality, outcomes studied, and inclusion in meta-analyses. Associations (ORs/RRs/HRs) are presented per $10{\text{-}\mu g/m}^{3}$ increment unless otherwise specified. Table S2 details the covariates included by each study in their primary adjusted models (although it is worth noting that case-only designs also adjust for all time-invariant confounders; i.e., those for which an individual's exposure remains constant over the timeframes studied---by design).

![Summary of results of quality assessment of studies of particulate air pollution and adult mental health outcomes considered eligible for inclusion in this review, outcomes assessed, and overview of inclusion in meta-analyses. Quality was assessed using the Effective Public Health Practice Project (EPHPP) Quality Assessment Tool for Quantitative Studies ([@c72]; [@c5]; [@c96]), which was developed for evaluating public health research across heterogeneous study designs. We extended the list of study designs assigned a fair rating beyond those listed in the EPHPP Tool Dictionary. We rated all time-series analyses, case-crossover, and hierarchical cluster analyses as fair quality, provided case-crossover studies used bidirectional referent period selection. We rated all cross-sectional studies of associations with long-term PM exposure that used measured or modeled PM values from a period prior to (and not overlapping with) outcome assessment as fair to reflect the relative strength of these studies compared with typical cross-sectional studies with simultaneous exposure and outcome assessment; we rated those using an exposure period overlapping with or after outcome assessment as poor for study quality. We assigned overall ratings according to the EPHPP guidance (those with one poor rating were assigned an overall rating of fair; those with two or more, an overall rating of poor). See Table S3 for further information on the allocation of quality ratings for individual quality components. In the middle set of columns, the outcomes studied (indicated via tick marks) refer to any outcome related to the specified mental health outcome or diagnosis, such as physician diagnosis, meeting a specified threshold on a diagnostic scale, measures of symptom severity, hospital or ED attendance, and in the case of suicide, suicide attempts, ideation, or suicide death. Inclusion in primary meta-analyses ([Figures 3](#f3){ref-type="fig"}, [5](#f5){ref-type="fig"}, and [@c6] and funnel plots in [Figure 4](#f4){ref-type="fig"}) is indicated via tick marks in the right-hand set of columns; the numbers and letters of the sensitivity meta-analyses indicated via an S correspond to those detailed in [Table 4](#t4){ref-type="table"}. Note: ED, emergency department; L-T, long term ($\geq 6\text{ \ months}$) PM exposure (exposure assessment period $\geq 6\text{ \ months}$); N/A, not applicable; PM, particulate matter; ${PM}_{10}$, particulate matter of $< 10\;\mu m$ in aerodynamic diameter; ${PM}_{2.5}$, particulate matter of $< 2.5\;\mu m$ in aerodynamic diameter; S-T, short term ($< 6\text{ \ months}$) PM exposure (exposure assessment period $< 6\text{ \ months}$).](ehp-127-126002-g002){#f2}

Study Quality {#s3.1}
-------------

Study quality varied substantially ([Figure 2](#f2){ref-type="fig"}). Overall, we rated quality more highly in studies of short- than long-term exposure, partly due to the case-only designs' advantages regarding confounder adjustment---given that many important confounders (such as individual socioeconomic status, physical activity, smoking status, and area-level deprivation), do not vary over short timeframes when individuals act as their own controls---along with their narrower epidemiological scope (given that they can only compare transient, acute effects rather than provide evidence about the etiology of more chronic exposure--outcome relationships). We rated many studies fair or poor regarding selection bias because few selection strategies ensured that participants were very likely to be representative of the target population, and some reported participation rates $< 60\%$ at enrollment, as in [@c115] (Substudies A and C; LifeLines and HUNT, respectively), or did not report this (e.g., [@c52]; [@c115] (Substudy B; KORA), [@c105]).

We rated four of the studies of long-term PM exposure \[[@c115] (Substudies A--C; LifeLines, KORA, and HUNT) and [@c100]\] as poor overall due to two or more poor component ratings. It should be noted that some studies were rated moderate overall according to EPHPP guidance, within which a poor global rating was assigned to studies with two or more poor component ratings, despite potentially significant weaknesses in a specific area, if they did not have two poor scores. For example, we rated both the KORA and FINRISK studies \[Substudies B and D in the meta-analysis by Zijlema et al. ([@c115])\] poor on study design because in both cases exposure assessment was based on models created using monitoring data collected significantly after clinical outcomes were assessed, although using concurrent address data.

Studies investigating associations between long-term PM exposure and mental health outcomes (which tend to compare exposure and risk differences between individuals) are primarily susceptible to confounding by time-invariant confounders that may co-vary with both air pollution and mental health. Some studies failed to control for confounders that we considered likely to be particularly important (e.g., socioeconomic status/deprivation, urbanity), as in the HUNT subcohort in Zijlema et al. ([@c115]), which included neither of these, or did so only partially (e.g., [@c52]; [@c100]). By contrast, several other studies controlled for socioeconomic status reasonably comprehensively (e.g., [@c53]; [@c55]; [@c63]; [@c88]; [@c87]). Some other potentially influential confounders were rarely included in analyses; for example, no included study adjusted for access to green space and only the substudies by Zijlema et al. ([@c115]) included noise. However, the results of these substudies had very wide confidence intervals (CIs), in analyses with and without adjustment for noise exposure, which the authors noted could have been due to model overfitting and comparatively low exposure variability.

Although relatively robust to time-invariant confounders, case-only studies (which compare changes in risk associated with short-term exposure within the included individuals, who all experience the outcome of interest over the study period) remain susceptible to time-varying confounders such as temperature ([@c79]; [@c83]) and seasonal and long-term trends ([@c20]). These were generally well controlled (see Table S3 for covariates adjusted for), leading to most case-only studies being assigned a confounding rating of good. However, temporal variation in noise levels was not adjusted for by any studies of short-term exposure.

Studies of Associations with Long-Term PM Exposure ($\geq 6\text{-}Month$ Exposure Period) {#s3.2}
------------------------------------------------------------------------------------------

We identified 8 studies of associations with long-term exposure ([Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}), including 1 meta-analysis ([@c115]) that comprised 4 previously unpublished primary studies, each of which we considered individually, giving 11 in total. Two of these ([@c88]; [@c87]) also investigated associations between short-term exposure and one or more eligible mental health outcomes. Of these 11 studies, 9 investigated associations of any eligible outcome with long-term ${PM}_{2.5}$ exposure and 6 with long-term ${PM}_{10}$ exposure (these totals include 4 studies that investigated both long-term ${PM}_{2.5}$ and ${PM}_{10}$ exposure; [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}).

Depression {#s3.3}
----------

Two eligible cohort studies ([@c53]; [@c55]) and seven cross-sectional studies, including four substudies from Zijlema et al.'s paper \[[@c52]; [@c63]; [@c88]; [@c100]; [@c115] (Substudies A--D)\] looked at associations between long-term PM exposure and depression.

Outcomes included depression incidence ([@c53]; [@c55]) and prevalence---based on either score on a screening instrument indicating moderate-to-severe depressive symptoms \[[@c88]; [@c115] (Substudies C and D)\], or meeting diagnostic criteria on a validated diagnostic instrument \[[@c115] (Substudies A and B)\]. Another study ([@c63]) used the validated World Mental Health Survey version of the Composite International Diagnostic Interview (WMH-CIDI) and defined depression as any of the following: depressive symptoms within the past year, meeting diagnostic criteria for research (based on WMH-CIDI), and/or having received depression-related health care. This study partially involved self-report of diagnosis or health care utilization; however, we rated outcome assessment moderate because this self-reported outcome data was used alongside a valid and reliable instrument.

Of the seven cross-sectional studies, five \[[@c63]; [@c115] (Substudies A, B and D); [@c88]\] met criteria for inclusion in the primary meta-analysis of associations between long-term ${PM}_{2.5}$ exposure and depression. Results of the sensitivity meta-analyses are shown in [Table 4](#t4){ref-type="table"} and the reasons for exclusion of other studies from the meta-analyses are detailed in Table S5.

###### 

Results of sensitivity analyses (random effects meta-analyses) of associations between long-term ${PM}_{2.5}$ or ${PM}_{10}$ exposure (exposure assessment periods of $\geq 6\text{ \ months}$ duration) and odds of depression.

Table 4 lists sensitivity analysis number and exposure (PM type) in the first and the second columns, respectively. The sensitivity analysis description (Changes made from corresponding primary meta-analysis), Pooled effect size (OR) per 10 micrograms per cubic meter, Lower 95 percent CI:, Upper 95 percent CI:, p-value (Z-test of the null hypothesis of no effect), Cochran's Q, p-value for Cochran's Q, and I squared statistic are listed in the other columns.

  Sensitivity analysis number   Exposure (PM type)   Sensitivity analysis description (changes made from corresponding primary meta-analysis)                                                                                                              Pooled effect size (OR) per $10{\,\mu g/m}^{3}$   Lower 95% CI   Upper 95% CI   *p*-Value (*Z*-test of the null hypothesis of no effect)   Cochran's *Q* (df)   *p*-Value for Cochran's *Q*   $I^{2}$ statistic (%)
  ----------------------------- -------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------- -------------- -------------- ---------------------------------------------------------- -------------------- ----------------------------- -----------------------
  1a                            ${PM}_{2.5}$         Including HRs from Kim et al. ([@c53]) and Kioumourtzoglou et al. ([@c55]) in meta-analysis (i.e., assuming equivalence between HRs and ORs as measures of effect size)*^a^*                          1.113                                             1.003          1.234          0.043                                                      7.54 (6)             0.274                         20.4
  1b                            ${PM}_{2.5}$         Including studies reporting ORs that were excluded on the basis of the outcome definition used ([@c100])                                                                                              1.259                                             0.874          1.813          0.217                                                      9.23 (5)             0.100                         45.8
  1c                            ${PM}_{2.5}$         Use of alternate exposure time period \[4 y rather than 1-y ${PM}_{2.5}$ exposure results from Pun et al. ([@c88])\]                                                                                  1.111                                             1.031          1.198          0.006                                                      1.45 (4)             0.835                         0.00
  2a                            ${PM}_{10}$          Inclusion of the same studies as the primary meta-analysis but using the alternative exposure assessment model in Zijlema et al. ([@c115]) (where EU-model estimates available)                       1.484                                             0.602          3.654          0.391                                                      4.92 (2)             0.085                         59.40
  2b                            ${PM}_{10}$          Including studies excluded from the primary meta-analysis on the basis of the outcome definitions used \[Vert et al. ([@c100]) and Kim et al. ([@c53]) were included in this sensitivity analysis\]   1.097                                             0.607          1.981          0.76                                                       9.32 (4)             0.054                         57.10

Note: df = degrees of freedom; EU-model, European Union model; HR, hazard ratio; OR, odds ratio; ${PM}_{10}$, particulate matter of $< 10\;\mu m$ in aerodynamic diameter; ${PM}_{2.5}$, particulate matter of $< 2.5\;\mu m$ in aerodynamic diameter; RR, relative risk.

This analysis (1a) used results from the 12-month moving average exposure measure in Kim et al. ([@c53]) study (adjusted Model 4) and adjusted 12-month results for self-reported depression diagnosis from [@c55].

### Long-term $PM_{2.5}$ and depression. {#s3.3.1}

In meta-analysis, the pooled OR for the association between long-term ${PM}_{2.5}$ exposure and depression prevalence ([Figure 3](#f3){ref-type="fig"}; $n = 5$ studies) was 1.102 per $10{\,\mu g/m}^{3}$ (95% CI: 1.023, 1.189; $p = 0.011$), indicating that higher ${PM}_{2.5}$ exposure is associated with higher odds of depression. The $I^{2}$ statistic was 0.00%, suggesting low statistical heterogeneity among the included studies. Evidence of publication bias was not evident in the funnel plot ([Figure 4A](#f4){ref-type="fig"}), and this was further supported by the results of Egger's regression test for small-study effects ($H_{0} = \text{no\  \ small-study}$ effects; $p = 0.311$).

![Forest plot of meta-analysis of associations between long-term ($\geq 6\text{-\ months}$) ${PM}_{2.5}$ exposure and depression risk ($n = 5$ studies). Results of meta-analysis are shown as pooled effect estimates of the OR of depression per $10{\,\mu g/m}^{3}$ (95% CIs). The dashed vertical line indicates the overall effect estimate derived from DerSimonian-Laird random effects meta-analysis ([@c31]), and the blue diamond indicates the 95% CI of the overall (pooled) effect estimate. The horizontal lines indicate the 95% CI around each study's central estimate for the adjusted OR (shown with a closed circle); arrowheads at the end of these lines indicate where the true location of the end of a line is not shown (for scale reasons) and the upper or lower 95% CI is farther from the central estimate, in the direction of the arrowhead. The percentage weights are weightings assigned to individual studies' results in the DerSimonian-Laird random effects meta-analysis, and the sizes of the shaded squares around each effect estimate are scaled according to these relative weightings. The *p*-value of 0.972 shown at the bottom left is derived from a test of the null hypothesis of heterogeneity (Cochran's *Q*). Covariates adjusted for are detailed in Table S2. Note: CI, confidence interval; OR, odds ratio; ${PM}_{2.5}$, particulate matter of $< 2.5\;\mu m$ in aerodynamic diameter.](ehp-127-126002-g003){#f3}

![Funnel plots for all primary meta-analyses. Primary meta-analysis of depression with long-term (A) ${PM}_{2.5}$ and (B) ${PM}_{10}$ exposure. Meta-analysis of suicide risk with short-term ${PM}_{10}$ exposure, (C) $\text{lag} =$ 0-1 d and (D) $\text{lag\  } =$ 0-2 d. A summary of the studies included in each funnel plot is shown in [Figure 2](#f2){ref-type="fig"}; those indicated by tick marks in the right-hand column are included in primary meta-analyses. Funnel plots for sensitivity meta-analyses, the results of which are detailed in [Table 4](#t4){ref-type="table"}, are not included in this figure. The dark blue circles represent the central estimates for each included study or substudy's results; the dashed diagonal lines represent pseudo 95% confidence intervals and the solid vertical lines represent the natural logarithm of the overall effect estimate. Note: L-T, long-term ($\geq 6\text{ \ months}$) PM exposure (exposure assessment period $\geq 6\text{ \ months}$); lnOR, natural logarithm of the odds ratio; lnRR, natural logarithm of the relative risk (both presented per $10{\,\mu g/m}^{3}$ increase in ${PM}_{10}$ or ${PM}_{2.5}$ exposure); SE, standard error; S-T, short-term ($< 6\text{ \ months}$) PM exposure (exposure assessment period $< 6\text{ \ months}$).](ehp-127-126002-g004){#f4}

We conducted a sensitivity meta-analysis ([Table 4](#t4){ref-type="table"}, Row 1a) in which we also included HRs for ${PM}_{2.5}$ exposure from the two observational cohort studies, the first of which found statistically significant positive associations with incidence of recorded depression diagnoses ([@c53]) and another that did not find a statistically significant association with self-report of diagnosis ([@c55]). This gave a similar pooled estimated effect size but a wider confidence interval ($\text{OR} = 1.113$; 95% CI: 1.003, 1.234; $p = 0.043$) and evidence of somewhat greater between-study heterogeneity; $I^{2}$ was slightly increased at 20.4%. Another ${PM}_{2.5}$ sensitivity meta-analysis ([Table 4](#t4){ref-type="table"}, Row 1b) showed that including a study ([@c100]) that used self-reported depression and included a select population who were screened at study enrollment to ensure that they did not have major depressive disorder (potentially biasing this study) resulted in a less precise statistically nonsignificant pooled estimate and increased heterogeneity compared with the primary ${PM}_{2.5}$ depression meta-analysis ($\text{OR} = 1.259$; 95% CI: 0.874, 1.813; $p = 0.217$; $I^{2} = 45.8\%$). Vert et al. ([@c100]) found a positive OR of 4.38 per $5{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$ (95% CI: 1.70, 11.30). In a third sensitivity meta-analysis ([Table 4](#t4){ref-type="table"}, Row 1c), changing the exposure time period from which we selected results from Pun et al. ([@c88]) did not significantly change the pooled effect estimate or increase heterogeneity \[pooled $\text{OR} = 1.11$ (95% CI: 1.031, 1.198; $p = 0.006$; $I^{2}$ 0.00%)\].

### Long-term $PM_{10}$ and depression. {#s3.3.2}

As [Figure 5](#f5){ref-type="fig"} shows, the overall (pooled) result for the primary ${PM}_{10}$ meta-analysis ($n = 3$ studies, all from [@c115]) was not statistically significant at the conventional 5% level and showed no clear association. The pooled OR we found was 0.891 (95% CI: 0.504, 1.577) per $10{\,\mu g/m}^{3}$; $p = 0.692$ and $I^{2}$ was 0.00% ($p_{\text{heterogeneity}} = 0.638$), again representing low heterogeneity. The funnel plot for this meta-analysis is shown in [Figure 4B](#f4){ref-type="fig"}. In Egger's regression test for small-study effects, $p = 0.128$; suggesting no clear evidence of publication bias (but given the $p < 0.10$ threshold recommended by Egger et al. ([@c36]), it cannot be definitively excluded). Zijlema et al. ([@c115]) used two ${PM}_{10}$ exposure models; we included results based on the European Study of Cohorts for Air Pollution Effects (ESCAPE) study (rather than EU-wide) land-use regression model exposure estimates in this primary ${PM}_{10}$ meta-analysis because these were described as region-specific estimates based on intensive monitoring campaigns and local predictors (e.g., traffic counts), and we judged them as likely to be more accurate and to capture a greater degree of air pollution variability in the study location than the EU-wide model.

![Forest plot of meta-analysis of associations between long-term ($\geq 6\text{-\ months}$) ${PM}_{10}$ exposure and depression risk ($n = 3$ studies). Results of meta-analysis are shown as pooled effect estimates of the OR of depression per $10{\,\mu g/m}^{3}$ (95% CIs). The dashed vertical line indicates the overall effect estimate derived from DerSimonian-Laird random effects meta-analysis, and the blue diamond indicates the 95% CI of the overall (pooled) effect estimate. The horizontal lines indicate the 95% CI around each study's central estimate for the adjusted OR (shown with a closed circle); the arrowhead at the end of the line for [@c115], Substudy A (LifeLines) indicates that the true end of this line is not shown (for scale reasons) and the lower 95% CI is farther from the central estimate. The percentage weights are weightings assigned to individual studies' results in the DerSimonian-Laird random effects meta-analysis, and the sizes of the shaded squares around each effect estimate are scaled according to these relative weightings. The *p*-value of 0.638 shown at the bottom left is derived from a test of the null hypothesis of heterogeneity (Cochran's *Q*). Covariates adjusted for by individual studies are detailed in Table S2. Note: CI, confidence interval; OR, odds ratio; ${PM}_{10}$, particulate matter of $< 10\;\mu m$ in aerodynamic diameter.](ehp-127-126002-g005){#f5}

In a sensitivity analysis of the ${PM}_{10}$ meta-analysis, we tested the impact of using EU-wide ${PM}_{10}$ land-use regression model results for the two eligible Zijlema et al. ([@c115]) substudies for which these were available (LifeLines/Substudy A, where the corresponding main model OR was higher, and statistically significant; and KORA/Substudy B, in which it was lower, than the corresponding ESCAPE model results). We also sensitivity analyzed the impact of including two studies that we had excluded from the primary meta-analysis due to the unvalidated outcome definitions used ([@c100]; [@c52]) and the exclusion of individuals with diagnosed depression at baseline by Vert et al. ([@c100]). Vert et al. ([@c100]) found a large statistically significant association between ${PM}_{10}$ and self-reported depression disorders, with a wide confidence interval ($\text{OR} =$ 6.52; 95% CI: 1.82, 23.35), whereas Kim and Kim ([@c52]) did not find a statistically significant association between ${PM}_{10}$ and depressive symptoms ($\text{OR} =$ 1.01; 95% CI: 0.98, 1.05). [Table 4](#t4){ref-type="table"} (Rows 2a,b) shows results of these sensitivity meta-analyses. We obtained positive but statistically nonsignificant pooled estimates with wide confidence intervals and moderate between-study heterogeneity in both sensitivity analyses ($I^{2}$ values of 59.4% and 57.1%, respectively).

The HUNT substudy from Zijlema et al. ([@c115]; Substudy C) was excluded from the ${PM}_{10}$-depression meta-analysis and sensitivity analyses because it lacked the requisite minimal confounder set of indicators of urbanicity and socioeconomic status/deprivation. The extended confounder model for this study was adjusted only for age, sex, and three medical comorbidities, and the OR derived using this model was 0.39 (95% CI: 0.21, 0.70). This substudy did not have ${PM}_{2.5}$ data.

Anxiety {#s3.4}
-------

Two studies ([@c87]; [@c88]) investigated anxiety using validated screening instruments and both individually found statistically significant positive associations between ${PM}_{2.5}$ exposure and risk of anxiety symptoms above a threshold that was considered clinically relevant. Another study ([@c100]) included self-reported anxiety as an outcome but was excluded from primary meta-analyses (see Table S5 for details). We therefore did not conduct meta-analysis because there were too few eligible studies.

Pun et al. ([@c88]) found generally stronger associations between ${PM}_{2.5}$ and moderate-to-severe anxiety symptoms (operationalized as a Hospital Anxiety and Depression Score-A (HADS-A) score $\geq 8$) than did Power et al. ([@c87]) using a cutoff of 6 or more points on the less commonly used Crown-Crisp Index (CCI) phobic anxiety subscale, although both were significant at a range of cumulative lags. Pun et al. ([@c88]) reported adjusted ORs of 1.39 (95% CI: 1.15, 1.69) and 1.34 (95% CI: 1.12, 1.61) per $5{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$ increment over 1- and 4-y cumulative lags, respectively, whereas Power et al. reported adjusted ORs per $10{\text{-}\mu g/m}^{3}$ increment of ${PM}_{2.5}$ of 1.15 (95% CI: 1.06, 1.25) for a 1-y cumulative lag and 1.09 (95% CI: 1.01, 1.18) for cumulative exposure over the 15 y before outcome assessment in 2004 (average ${PM}_{2.5}$ at participants' recorded residential address from 1988 to 2003). The CCI subscale has been validated as differentiating anxiety and phobias from depression and healthy controls ([@c28]; [@c69]), and the cutoff adopted was based on previous evidence that this represents a clinically important threshold ([@c77]; [@c70]); however, CCI scores may measure a different form of anxiety from HADS-A.

Other Outcomes {#s3.5}
--------------

We did not identify any eligible studies investigating associations between long-term ${PM}_{2.5}$ or ${PM}_{10}$ exposure and bipolar disorder (or manifestations thereof including mania). We also did not find any study associations between long-term ${PM}_{2.5}$ or ${PM}_{10}$ exposure and psychosis or suicide which met our inclusion criteria.

Population Attributable Fraction Estimates {#s3.6}
------------------------------------------

We estimated illustrative PAFs for two scenarios (UK cities and global) based on the pooled estimate from our meta-analysis of associations between long-term ${PM}_{2.5}$ exposure and depression, assuming causality and a log-linear exposure--response function (calculations detailed in Table S4). However, it should be noted the observed relationship may be due to bias and/or confounding rather than a causal association.

This analysis suggested that if urban UK population-weighted ${PM}_{2.5}$ exposure ($12.8{\,\mu g/m}^{3}$ in 2014) were reduced to the WHO's recommended annual maximum ($10.0{\,\mu g/m}^{3}$) ([@c57]), city-dwelling UK citizens' depression risk could, potentially, be reduced by approximately 2.5% (95% CI: 0.58, 4.34%). If global mean population-weighted ${PM}_{2.5}$ exposure ($43.9{\,\mu g/m}^{3}$) were reduced to a population-weighted mean ${PM}_{2.5}$ exposure of $25.0{\,\mu g/m}^{3}$ (the current EU-recommended limit), depression risk could be reduced by up to 15.2% (95% CI: 3.85, 25.9%).

Studies of Associations with Short-Term PM Exposure (Exposure Lags $< 6\, Months$) {#s3.7}
----------------------------------------------------------------------------------

Sixteen studies investigated short-term associations between PM and eligible psychiatric outcomes ([Tables 2](#t2){ref-type="table"} and [3](#t3){ref-type="table"} list study citations and data extracted). Twelve used case-only designs (e.g., case-crossover and time-series analysis), which are well suited for studying acute effects. Eleven investigated short-term associations between any eligible mental health outcome and ${PM}_{2.5}$ and 13 investigated associations of eligible outcomes with ${PM}_{10}$ (six analyzed both); 1 ([@c105]) also investigated associations with UFP exposure.

Suicide (Attempted or Completed) {#s3.8}
--------------------------------

Six studies ([@c8]; [@c21]; [@c51]; [@c54]; [@c62]; [@c76]) investigated associations between short-term PM exposure and risk of completed suicide (using mortality register data), and one study investigated associations with suicide attempt or ideation ([@c95]). The results of a majority of eligible studies investigating short-term associations with risk of completed suicide and ${PM}_{10}$ exposure indicated a positive association, with a statistically significant pooled result from primary meta-analysis at lag 0-2 d.

Only two studies investigated associations between completed suicide and ${PM}_{2.5}$ at any lags, so meta-analysis of associations between ${PM}_{2.5}$ and completed suicide was not possible. We were only able to meta-analyze studies of associations between ${PM}_{10}$ and completed suicide at lags 0-1 d ($n = 3$) and 0-2 d ($n = 4$) because fewer than three studies included all other time lags studied. All studies considered eligible for inclusion in these meta-analyses reported relative risks, except for Lin et al. ([@c62]), who reported odds ratios; we considered the odds ratios from Lin et al. ([@c62]) equivalent to relative risks on the basis of the rare outcome assumption, so we reported pooled effect size estimates as relative risks. Results are shown in [Figure 6](#f6){ref-type="fig"}. Pooled effect estimates per $10{\text{-}\mu g/m}^{3}$ ${PM}_{10}$ increment were nonsignificant at lag 0-1 d ($\text{RR} = 1.01$, 95% CI: 0.99, 1.03; $I^{2} = 44.6\%$) but statistically significant at the 95% level at lag 0-2 d, with $\text{RR} =$ 1.02 (95% CI: 1.00, 1.03; $p = 0.031$; $I^{2} = 43.5\%$). $I^{2}$ was 44.6% and 43.5% in these meta-analyses, respectively, representing moderate between-study heterogeneity. Funnel plots of the 0-1 and 0-2 d lag meta-analyses are shown in [Figure 4C](#f4){ref-type="fig"} and [D](#f4){ref-type="fig"}, respectively; Egger's test of small study effects ($H_{0} = \text{no\  \ small-study\  \ effects}$) produced results of $p = 0.779$ and $p = 0.413$ at lags 0-1 and 0-2, respectively.

![Forest plot of meta-analyses of associations between short-term ${PM}_{10}$ exposure and risk of completed suicide (relative risk per ${10\;\mu g/m}^{3}$), at cumulative lags 0-1 and 0-2 d. Results of meta-analysis are shown as pooled effect estimates for RR of depression per $10{\,\mu g/m}^{3}$ ${PM}_{10}$ (95% CIs). Lag 0-1 refers to the cumulatively lagged values (moving average) of concentrations across Day 0 (the day of the outcome event) and Day $- 1$ (the previous day), whereas Lag 0-2 refers to the cumulative lagged values across Days 0, $- 1$, and $- 2$. The dashed lines indicate the overall effect estimates, separately for each cumulative lag, derived from DerSimonian-Laird random effects meta-analysis, and the diamond indicates the 95% CI of the overall (pooled) effect estimate. The horizontal lines indicate the 95% CI around each study's central estimate for the adjusted RR at this exposure time lag (shown with a closed circle); the arrowhead at the right end of the line for Bakian et al. ([@c8]) at lag 0-2 d indicates that the true location of the upper 95% CI for this study is farther from the central estimate. The percentage weights are weightings of the individual studies in the DerSimonian-Laird random effects meta-analysis, and the sizes of the shaded squares around each effect estimate are scaled according to these relative weightings. The *p*-values at the bottom left are from a test of the null hypothesis of heterogeneity (Cochran's *Q*). The covariates that each study adjusted for are detailed in Table S2. Note: CI, confidence interval; ${PM}_{10}$, particulate matter of $< 10\;\mu m$ in aerodynamic diameter; RR, relative risk.](ehp-127-126002-g006){#f6}

A majority of the associations with completed suicide reported by individual studies were positive at a range of short-term lags, particularly for ${PM}_{10}$, although not all were statistically significant. Only the study by Ng et al. ([@c76]) reported no consistent direction of association. Although most of these studies focused on lag periods of $< 1\text{ \ week}$, Kim et al. ([@c54]) also found statistically significant associations between short-term ${PM}_{10}$ concentrations and the nationwide weekly suicide rate at 2-, 3-, and 4-week lags, including a 3.6% increase (95% CI: 1.5, 5.7%) per $37.8{\text{-}\mu g/m}^{3}$ ${PM}_{10}$ increment at a 4-week (single week) lag, but they found no statistically significant association at either the 5- or 6-week time lags studied.

In addition, Szyszkowicz et al. ([@c95]) defined all ED visits coded as suicide attempt or ideation as cases and observed positive but nonsignificant associations for ${PM}_{10}$ and ${PM}_{2.5}$. However, unstratified results were presented only graphically; we requested numerical results, but these were not received and so could not be included in the meta-analyses.

Depressive Episode Exacerbation and Depressive Symptom Severity {#s3.9}
---------------------------------------------------------------

Seven studies investigated associations between short-term ${PM}_{10}$ or ${PM}_{2.5}$ exposure and outcomes such as ED attendance for depressive episodes ([@c24]; [@c90]; [@c92], [@c91]) or depressive symptoms ([@c61]; [@c88]; [@c105]). Short-term increases in PM exposure appear to be positively associated with depression-related ED attendance risk, whereas the evidence regarding associations between short-term PM exposure and depressive symptom severity is more mixed; we did not conduct meta-analysis of results for these outcomes. We did not undertake meta-analysis of associations of short-term PM exposure with these outcomes due to the heterogeneity of the time lags analyzed and a lack of numeric reporting of unstratified results in two studies of ED attendances, meaning that---for each lag considered---there were fewer than three studies using the same exposure lags. Most of the above studies found positive associations with PM exposure at some of the exposure lags studied, with the exception of Wang et al. ([@c105]).

Cho et al. ([@c24]) observed statistically significant positive associations of ${PM}_{10}$ exposure with ED attendance for depression at five of the six lags studied, whereas two studies ([@c90]; [@c92]) both reported statistically significant positive associations between ${PM}_{10}$ and ED attendance for depression at some lags but were excluded from the meta-analysis (see Table S5 for details). Szyszkowicz et al. ([@c91]) found whole-year associations between depression-related ED attendances and ${PM}_{2.5}$ that were positive ($\text{ORs} > 1$) at a majority of the single-day lags, from 0 to 8 d (8 and 7 of the 9 lags studied, for males and females, respectively). However, they were only statistically significant in males at lag 3 d ($\text{OR} =$1.023 per $7.12{\,\mu g/m}^{3}$; 95% CI: 1.001, 1.045); results unstratified by sex were not reported.

Pun et al. ([@c88]) found positive associations between ${PM}_{2.5}$ exposure and symptoms indicative of depression \[operationalized as Centre for Epidemiologic Studies Depression (CESD)-11 score $\geq 9$\] at cumulative 7- and 30-day lags, with ORs of 1.08 (95% CI: 1.00, 1.16) and 1.16 (95% CI: 1.05, 1.29) per $5{\text{-}\mu g/m}^{3}$ increase in ${PM}_{2.5}$ exposure, respectively. Wang et al. ([@c105]) reported a significant negative association of 0-14 d cumulatively lagged ${PM}_{2.5}$ with the odds of a CESD Scale-Revised (CESD-R) score $\geq 16$ ($\text{OR} =$ 0.67; 95% CI: 0.46, 0.98 per $3.4{\text{-}\mu g/m}^{3}$ increase in ${PM}_{2.5}$). Lim et al. ([@c61]) reported an increase in an elderly population's mean score on the Korean Geriatric Depression Scale-Short Form ([@c7]) of 17.0% (95% CI: 4.9, 30.5%) per $24.2{\text{-}\mu g/m}^{3}$ increase in 0-3 d ${PM}_{10}$.

Anxiety Symptom Severity {#s3.10}
------------------------

The studies by Pun et al. ([@c88]) and Power et al. ([@c87]) both reported statistically significant associations between short-term ${PM}_{2.5}$ exposure and anxiety symptoms, in addition to the associations between long-term ${PM}_{2.5}$ exposure and anxiety discussed above. Pun et al. ([@c88]) reported adjusted ORs of 1.14 (95% CI: 1.05, 1.24) and 1.31 (95% CI: 1.20, 1.51) per $5{\text{-}\mu g/m}^{3}$ increment at 7- and 30-d cumulative lags, respectively, whereas Power et al. ([@c87]), using the Crown-Crisp Index Phobic Anxiety Subscale, reported ORs of 1.12 per $10{\,\mu g/m}^{3}$ (95% CI: 1.06, 1.19) at a 0- to 1-month cumulative lag; 1.13 per $10{\text{-}\mu g/m}^{3}$ increment (95% CI: 1.06,1.21) at a 0- to 3-month cumulative lag, and 1.14 per $10{\,\mu g/m}^{3}$ (95% CI: 1.05, 1.23) at a 0- to 6-month cumulative lag. We did not conduct meta-analysis because only these two studies investigated this outcome.

Other Outcomes {#s3.11}
--------------

No studies specifically investigated associations between PM and bipolar disorder. Gao et al. ([@c43]) found associations of borderline statistical significance between ${PM}_{10}$ and hospital admissions for all mood disorders (combined) of a 0.36% increase per $10{\text{-}\mu g/m}^{3}$ increment (95% CI: 0.06, 0.66%) at a 5-d single lag and statistically significant positive associations between ${PM}_{10}$ and hospital admissions for schizophrenia, which appeared strongest at a 0-6 d cumulative lag with a 1.38% increase per $10{\text{-}\mu g/m}^{3}$ increment (95% CI: 0.52, 2.23%).

Discussion {#s4}
==========

Our systematic review identified a statistically significant association between long-term ${PM}_{2.5}$ exposure and depression risk in our primary meta-analysis, which remained in two of three sensitivity analyses, whereas our primary and sensitivity meta-analyses of long-term ${PM}_{10}$ exposure and depression risk did not find any statistically significant association. Meta-analysis of studies reporting associations between short-term ${PM}_{10}$ exposure and completed suicide found a RR of 1.02 (95% CI: 1.00, 1.03) at a cumulative 0-2 d lag; the association at a 0-1 d lag was not statistically significant.

The more limited evidence available for anxiety suggests a possible association with increased PM exposure at both shorter- and long-term exposure timescales, although only two eligible studies ([@c87]; [@c88]) investigated this. The effect sizes observed in the studies of associations between long-term ${PM}_{2.5}$ exposure and depression and anxiety identified by our review are similar in magnitude to those observed for some physical health consequences of chronic air pollution exposure. For example, a $10{\text{-}\mu g/m}^{3}$ increase in long-term average ${PM}_{2.5}$ exposure appears to be associated with an approximately 10% increase in all-cause mortality ([@c117]).

We also observed an association between short-term ${PM}_{10}$ exposure and suicide risk at a 0-2 d cumulative time lag in meta-analysis, which was statistically significant at the 95% level. There is also some evidence to suggest an association between short-term ${PM}_{2.5}$ or ${PM}_{10}$ exposure and depression-related ED visits from individual studies, with several identifying statistically significant associations with ED attendances or depressive symptoms at some of the exposure lags studied, although their statistical significance may be affected by multiple comparisons. The smaller effect sizes observed in relation to short-term exposure relative to the larger magnitude of associations with long-term exposure are consistent with the results of studies of PM's physical health effects. In the review by Pope and Dockery ([@c86]) of meta-analyses and multicity studies, a $10{\text{-}\mu g/m}^{3}$ increase in mean daily ${PM}_{2.5}$ exposure was found to increase daily cardiovascular mortality risk by approximately 1.0%.

We identified no studies of associations with bipolar disorder and only one eligible study ([@c43]) of associations between PM and psychosis risk. That study found associations of borderline statistical significance between short-term PM exposure and inpatient admissions for mood disorders or schizophrenia. We excluded two studies of associations between short-term PM concentrations and psychosis from this review; the study by Lary et al. ([@c58]) of ED admissions for schizophrenia reported only the strength of correlations with specific schizophrenia diagnostic categories, rather than comparative effect estimates, whereas the study by Tong et al. ([@c97]) operationalized psychosis diseases as International Classification of Diseases (ICD)-10 codes F00--F99 (organic mental disorders; i.e., including psychiatric disorders with known biological causes such as brain tumors), and psychosis morbidity was undefined. In relation to associations between long-term PM exposure and psychosis risk, the two studies identified used proximity to a major road as a proxy for PM exposure, which did not meet inclusion criteria; we therefore excluded these studies from our review. An exploratory study by Pedersen et al. ([@c81]) identified a possible association with psychosis based on proximity to a major road, although a subsequent study by Pedersen and Mortensen ([@c80]) did not replicate this finding.

The estimated PAFs presented for ${PM}_{2.5}$ exposure and depression are intended to illustrate the disease burden that might be attributable to the association between long-term ${PM}_{2.5}$ exposure and depression observed in our meta-analysis if this relationship were established as causal and independent of the influence of potential confounding factors. These PAF estimates illustrate that this burden could---potentially---be similar in magnitude to some of air pollution's physical health effects (e.g., [@c15]). However, such causality has not been established, and our meta-analysis is subject to several limitations, so they should be interpreted as illustrative estimates of the potential attributable burden should this association be further substantiated in future, not as representing the actual burden.

Strengths and Limitations {#s4.1}
-------------------------

A key strength of this review is the comprehensive, systematic approach, with the protocol specified *a priori*, and searches conducted by two authors. We also used standardized data extraction and quality assessment procedures.

Our review covers a broader range of mental health outcomes than most previous reviews in this area, and we identified a moderate number of studies for some outcomes, enabling meta-analyses. However, we were only able to undertake three meta-analyses, together covering two of the five eligible outcomes, owing to the small numbers of studies with comparable exposure--outcome combinations for other mental health outcomes and incomplete reporting in two studies ([@c90]; [@c92]). Our review includes 20 studies (including the 4 within [@c115]) that have been published since the search by Tzivian et al. ([@c98]) of the literature up to November 2013. One further study of associations with psychosis, published since the review by Attademo et al. ([@c6]), was identified ([@c43]).

An important corollary of the typically small individual-level effect sizes of changes in PM exposure in relation to physical health outcomes (per $10{\text{-}\mu g/m}^{3}$ increment) is that very large sample sizes may be needed to detect such effects if the same applies for mental health. This is particularly relevant where adjusting for a large number of confounders and in settings where pollutant levels and variability are comparatively low, as in Europe or the United States. As a result, it is likely that some included studies were underpowered to detect a putative effect on the outcomes studied (particularly because power calculations require prior assumptions about likely effect size), making the use of meta-analysis particularly valuable.

The distinction made between short- and long-term exposures on the basis of a 6-month cutoff is somewhat arbitrary, but this did not significantly influence the meta-analytic results. Only one study ([@c87]) used exposure assessment periods of between 2 and 11 months' duration (3 and 6 months), and this study could not be included in the meta-analysis in any case due to the small number of eligible studies of this outcome (anxiety).

We did not detect evidence of publication bias but recognize that our review was restricted to published research in English-language journals. We also acknowledge the limitations of visual assessment of funnel plots for publication bias and that the power of statistical tests for small-sample effects such as Egger's test is low when analyzing only a small number of studies, as here. Heterogeneity in both methods and outcome definitions is reflected in our use of random-effects meta-analysis but may limit the generalizability of the results obtained, particularly given the limited number of studies we were able to include and the heterogeneity of study populations and settings.

The low $I^{2}$ value obtained in our primary meta-analysis of the association between long-term ${PM}_{2.5}$ and depression suggests that statistical heterogeneity of study results was not significant; this was the case in two of the three sensitivity meta-analyses conducted. This increases our confidence in the appropriateness of pooling these studies and in the result of this meta-analysis; however, it is subject to other limitations discussed below, including possible residual confounding. In addition, although more statistically powerful than Cochran's *Q*, $I^{2}$ has low power and can be biased as a test for heterogeneity in small meta-analyses ([@c103]). $I^{2}$ was higher in Sensitivity Analysis 1b, which included a study ([@c100]) that we considered at high risk of bias due to the overly restrictive eligibility criteria of the wider cohort study within which this study was nested (excluding participants with major depressive disorder at study enrollment). The suicide meta-analysis is perhaps less likely to be affected by heterogeneous outcome definitions than our depression meta-analysis, although some outcome misclassification is possible. However, we observed greater statistical heterogeneity in the meta-analyses of ${PM}_{10}$ and suicide risk (at 0-1 and 0-2 d) than with both meta-analyses of long-term PM exposure and depression, reducing our confidence in the results of this meta-analysis. We hypothesize that this may reflect differences between countries in the likelihood of outcome misclassification with respect to suicide; however, there are multiple possible explanations.

Ratings for several of the EPHPP quality criteria require a degree of judgment; for example, validity and reliability are not binary constructs so the component scores allocated for data collection methods necessarily reflect the authors' subjective assessment. Estimating whether a study has controlled for less or more than 80% (or 60%) of relevant confounders is similarly challenging and inherently somewhat subjective, particularly given incomplete scientific knowledge about causal relationships between some potential confounders, PM, and the different outcomes assessed. We took the view that studies could meet this threshold without adjustment for noise exposure, but it is possible that future studies will show noise to be a more significant risk factor for outcomes such as depression, anxiety, or suicide than is currently recognized. Because we did not restrict inclusion in meta-analysis based on EPHPP ratings, the tool's arbitrary quantification of confounding does not affect our meta-analytic results. However, due to limitations in the EPHPP tool's process for determining overall ratings and the small numbers of studies identified, our ability to explore the effect of variation in study quality on the meta-analytic results was limited.

The EPHPP tool is also not specifically designed for quality assessment of environmental epidemiology studies and therefore does not facilitate in-depth critical appraisal of air pollution exposure assessment methods. Nevertheless, there does not appear to be a more robust quality assessment tool applicable to a range of study designs.

Our findings are also affected by the limitations of the included studies, and particularly by the risk of residual and unmeasured confounding. Even in generally well-controlled studies of long-term exposure, such as those by Lin et al. ([@c63]), Pun et al. ([@c88]), and Kioumourtzoglou et al. ([@c55]), some degree of residual confounding due to socioeconomic status is likely. Noise exposure, particularly from traffic noise, is an important potential confounder, particularly for studies of long-term PM exposure because it is moderately spatially correlated with air pollution ([@c3]) and has been linked to psychological effects ([@c98]), including through sleep disturbance (e.g., [@c10]) and annoyance (e.g., [@c46]). Among the studies we identified, noise was only adjusted for in the four studies meta-analyzed by Zijlema et al. ([@c115]). We acknowledge that adjustment for such collinear factors is difficult and can produce unstable parameter estimates, which may at least partially underlie the significantly wider confidence intervals reported by Zijlema et al. ([@c115]) than in other included studies with comparable sample sizes. There is also a possibility that noise might act as an effect modifier of the relationship between PM and some psychiatric outcomes; however, this was not investigated by any eligible studies.

Green space is another possible confounder of a relationship between PM and at least some mental health outcomes given that they can directly improve air quality ([@c37]) and may reduce depression risk and improve mental health overall ([@c44]; [@c27]); however, it was not simultaneously adjusted for by any of the studies we identified.

However, several case-only studies with good time-varying confounder adjustment (as well as good adjustment for time-invariant confounders, by design) identified statistically significant associations between short-term PM exposure and suicide ([@c51]; [@c54]) and psychiatric admissions ([@c43]), providing a further line of evidence from a different study design, over shorter timescales, that PM exposure may alter psychological outcomes.

Another limitation of many included studies is that few adjusted for other air pollutants that are often spatiotemporally correlated with PM (and therefore inhaled alongside it) and which may also have physiological effects, including neuroinflammation. Most studies constructed only single-pollutant models, meaning that they could not exclude either confounding or effect modification by other pollutants such as sulfur, ozone, or nitrogen oxides. It was beyond the scope of our review to include all of the major air pollutants, although some studies met our inclusion criteria considered exposure to multiple air pollutants and found statistically significant associations with ozone (e.g., [@c61]; [@c91]).

Biases in routine data---for example regarding underreporting of suicide, case ascertainment in emergency departments, or approximating outcome incidence with hospital attendance---may further limit some studies' generalizability. The accuracy of register-based mortality data is affected by cultural and health system-related factors, as Afshari ([@c1]) discussed in relation to the study by Lin et al. ([@c62]), in which underreporting of suicide appears pronounced. Nevertheless, routine data sets often represent the most complete data available, and although associations with registered suicides may not generalize fully to unregistered suicides, differential case ascertainment (with respect to PM exposure) appears unlikely.

Exposure misclassification is a common problem in air pollution epidemiology (e.g., [@c111]), and a weakness of some studies included in our review is in the timing of exposure assessment. In particular, Zijlema et al. 's ([@c115]) KORA and FINRISK substudies (B and D) assessed outcomes before the intensive monitoring campaigns used in developing the ESCAPE exposure model, which undermines the accuracy of exposure assessment, limits the strength of this evidence regarding a temporal relationship, and makes it unclear which exposure--response lag is under investigation.

Area-level mean concentrations were used to estimate individual exposure in all case-only studies and one cross-sectional study, which used values for 25 districts ([@c52]). Most studies of long-term exposure comparing risk between individuals estimated individual exposure using land-use regression models to determine approximate concentrations at study participants' residential addresses as a surrogate for their long-term average exposure, at varying resolutions. High-resolution estimates are arguably less important in case-only studies investigating risk within individuals because spatial pollution gradients are typically correlated over time ([@c50]). Individuals' activity patterns also increase exposure misclassification; however, personal exposure monitoring remains prohibitively expensive for large-scale studies. Such exposure misclassification is more likely to be nondifferential with respect to psychiatric outcomes (and so bias results toward the null), necessitating larger samples to detect effects. In addition, area-level ambient air pollution exposure measures may introduce less risk of confounding by time-invariant factors such as socioeconomic status than personal exposure monitoring (see [@c106]), potentially making this a less significant limitation than might otherwise be assumed. Susceptibility to mental health effects of PM may also vary between individuals by, for example, age (e.g., [@c21]; [@c43]), sex ([@c8]; [@c42]), and socioeconomic status ([@c88]) and potentially by genotype (e.g., [@c74]; [@c104]). Lin et al. ([@c63]) also identified between-country differences in exposure--response functions. Furthermore, physical comorbidities may both confound and/or mediate the associations observed, for example, through inflammation ([@c11]; [@c30]) or psychological effects of physical symptoms ([@c102]). Some included studies observed stronger associations among individuals with chronic illnesses ([@c24]; [@c51]; [@c53]; [@c88]), although two ([@c55]; [@c61]) investigated this but did not find a difference.

Potential Biological Mechanisms {#s4.2}
-------------------------------

There is good evidence from human and animal studies that PM exposure induces oxidative and nitrosative stress and systemic and neuroinflammation ([@c12]; [@c59]) as well as being directly neurotoxic and associated with structural brain changes (e.g., [@c13]; [@c19], [@c17]). It has also been found to affect stress hormone production (e.g., [@c60]). A range of biological mechanisms, with these being among the most likely candidates, may underlie a putative association between PM and mental health outcomes.

Neuroinflammation appears to play an important role in both depression ([@c65]; [@c30]) and psychosis ([@c9]), and this may be involved in both shorter-term as well as more chronic effects of air pollution on mental health, as compared with neurotoxicity and changes in brain structure, which by their nature are more likely to be involved in chronic effects and which may be particularly important in relation to exposures in early life and adolescence. Inflammation and oxidative and nitrosative stress have been hypothesized as potential mediating pathways for other risk factors for depression, including psychosocial stressors, physical inactivity, obesity, and lack of sleep, and there is evidence from administration of cytokine infusions and antidepressants' effects, for example, that the relationship goes beyond simple correlation (see [@c11]).

Allen et al. ([@c2]) found that early exposure of mice to concentrated UFPs resulted in changes in CNS neurotransmitter levels and glial activation, whereas Fonken et al. ([@c39]) found that ${PM}_{2.5}$-exposed mice displayed more depressive-like responses and higher pro-inflammatory cytokines than mice exposed to filtered air. Calderón-Garcidueñas et al. ([@c18]) found an increased prevalence of prefrontal white matter lesions on brain magnetic resonance imaging (MRI) scans among children from a highly polluted area of Mexico City compared with children from a rural area, mirroring comparative MRI findings in young dogs. On histological examination, dogs exposed to high pollution were also found to have ultrafine PM deposition, gliosis, and vascular pathology associated with neuroinflammation. These may indicate mechanisms relevant to mental health impacts; for example, Chai et al. ([@c22]) described differences in prefrontal cortex functional connectivity in patients with schizophrenia and bipolar compared with controls, whereas Frodl et al. ([@c41]) found reduced prefrontal volume to be associated with depression duration.

Disruption of the HPA axis---which regulates the body's stress responses through the production of hormones such as cortisol---has emerged as a potentially important etiological factor in anxiety and depression (e.g., [@c116]; [@c66]). Supporting the possibility that PM exposure may act through this pathway, a robust association between indoor air pollution exposure and participants' serum cortisol levels was reported in Li et al. ([@c60])'s randomized double-blind crossover trial using indoor air purifiers.

Implications for Future Research and Policy {#s4.3}
-------------------------------------------

We suggest that a combination of the biological mechanisms discussed above are likely to be involved in mediating any effects of PM on mental health, if a causal association exists. However, at present, the precise pathways involved, and their relative importance across different timeframes and psychiatric conditions, are not well established. Further primary research---for example through animal studies, use of quasi-experimental or, where these can be conducted ethically, experimental studies involving humans, and the integration of toxicological and epidemiological methods in the same studies, is also needed to help further clarify the mechanisms involved. Future studies should also seek to build on current evidence by better addressing key potential environmental confounders such as traffic noise, access to green space, socioeconomic status, and chronic health conditions.

Mental health outcomes below a clinical threshold, such as stress and subjective well-being, were beyond the scope of our review but may have a comparable or even greater population health impact than diagnosable mental disorders. An innovative recent study by Zheng et al. ([@c114]) analyzed 210 million geotagged tweets from the social media platform Sina Weibo; they found a statistically significant negative association between ${PM}_{2.5}$ and the expressed happiness in the tweets' content; moreover, this association persisted when analyzing only exogenous ${PM}_{2.5}$ variation (pollution from neighboring cities), mitigating the risk of confounding by local factors such as noise or congestion. The use of such innovative study designs is likely to be crucial in answering as-yet unanswered questions about air pollution's mental health effects, including around causality.

The generalizability of our findings is restricted by methodological limitations in individual studies, methodological heterogeneity, the relatively small number of studies, and the possibility of publication bias. In view of these limitations and the potentially significant mental health risks that may be posed by PM exposure, particularly over the longer term, further high-quality studies are warranted to more fully investigate the exposure--response relationships and mechanisms involved. In particular, larger-scale longitudinal studies using validated outcome measures, representative samples, and improved adjustment for area-level confounders such as noise and green space are needed to further interrogate the nature and potential causality of the associations observed.

Our results appear to support the hypothesis of an association with multiple adverse mental health outcomes, most clearly depression, for which we observed a statistically significant positive association in meta-analysis (pooled $\text{OR} =$ 1.10; 95% CI: 1.02, 1.19) per $10{\text{-}\mu g/m}^{3}$ ${PM}_{2.5}$ increment. The possibility of causal associations between air pollution and adverse mental health outcomes raises equity concerns given that deprivation is known to adversely affect mental health (e.g., [@c38]), whereas poorer areas often have more polluted air ([@c49]). There are, nevertheless, valuable opportunities to reduce the burden of both mental and physical ill health and health inequalities simultaneously through well-designed policies to improve air quality, such as by promoting active travel and urban green spaces, which also have psychological benefits ([@c44]; [@c109]).
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